0000950142-18-001739.txt : 20180813
0000950142-18-001739.hdr.sgml : 20180813
20180813103628
ACCESSION NUMBER: 0000950142-18-001739
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180630
FILED AS OF DATE: 20180813
DATE AS OF CHANGE: 20180813
EFFECTIVENESS DATE: 20180813
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aisling Capital LLC
CENTRAL INDEX KEY: 0001571076
IRS NUMBER: 010849048
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-15878
FILM NUMBER: 181010737
BUSINESS ADDRESS:
STREET 1: 888 SEVENTH AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
BUSINESS PHONE: 212-651-6372
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001571076
XXXXXXXX
06-30-2018
06-30-2018
false
Aisling Capital LLC
888 Seventh Avenue, 12th Floor
New York
NY
10106
13F HOLDINGS REPORT
028-15878
N
Robert Wenzel
Chief Financial Officer
212-651-6374
/s/ Robert Wenzel
New York
NY
08-13-2018
0
9
761879
INFORMATION TABLE
2
infotable.xml
ADMA BIOLOGICS INC.
COM
000899104
16273
3608171
SH
SOLE
3608171
0
0
AIMMUNE THERAPEUTICS INC.
COM
00900T107
60234
2240000
SH
SOLE
2240000
0
0
CHIMERIX INC.
COM
16934W106
2251
472943
SH
SOLE
472943
0
0
CIDARA THERAPEUTICS INC.
COM
171757107
5310
1021148
SH
SOLE
1021148
0
0
LOXO ONCOLOGY INC.
COM
548862101
596584
3438920
SH
SOLE
3438920
0
0
PERNIX THERAPEUTICS HLDGS INC.
COM NEW
71426V306
510
210000
SH
SOLE
210000
0
0
PERNIX THERAPEUTICS HLDGS INC.
DEBT 4.250% 4/0
71426VAK4
1091
2500000
PRN
SOLE
2500000
0
0
TRANSENTERIX INC.
COM NEW
89366M201
27858
6389352
SH
SOLE
6389352
0
0
VIEWRAY INC.
COM
92672L107
51768
7480887
SH
SOLE
7480887
0
0